CURELINE TRANSLATIONAL CRO Trademark

Trademark Overview


On Tuesday, October 27, 2020, a trademark application was filed for CURELINE TRANSLATIONAL CRO with the United States Patent and Trademark Office. The USPTO has given the CURELINE TRANSLATIONAL CRO trademark a serial number of 90280803. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by Cureline, Inc.. The CURELINE TRANSLATIONAL CRO trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Human organ and tissue bank services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, performing laboratory histopathology and molecular analytic tests for diagnostic and treatment purposes

Biomedical research services for human specimen banking and laboratory analyses, namely, designing research protocols, drug research and development, research and development in the pharmaceutical and biotechnology fields concerning human tissue and molecular and cellular assays
cureline translational cro

General Information


Serial Number90280803
Word MarkCURELINE TRANSLATIONAL CRO
Filing DateTuesday, October 27, 2020
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6625441
Registration DateTuesday, January 25, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Description of MarkThe mark consists of the word "CURELINE" surrounded by a partial circle design, and the words "TRANSLATIONAL CRO" found below in uppercase lettering.
Pseudo MarkCURE LINE TRANSLATIONAL CONTRACT RESEARCH ORGANIZATION
Indication of Colors claimedThe color(s) red and varying shades of grey is/are claimed as a feature of the mark.
Goods and ServicesHuman organ and tissue bank services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, performing laboratory histopathology and molecular analytic tests for diagnostic and treatment purposes
NOT AVAILABLE"TRANSLATIONAL CRO"
Goods and ServicesBiomedical research services for human specimen banking and laboratory analyses, namely, designing research protocols, drug research and development, research and development in the pharmaceutical and biotechnology fields concerning human tissue and molecular and cellular assays

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 16, 2020
Primary Code042
First Use Anywhere DateWednesday, October 21, 2020
First Use In Commerce DateWednesday, October 21, 2020

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 16, 2020
Primary Code044
First Use Anywhere DateWednesday, October 21, 2020
First Use In Commerce DateWednesday, October 21, 2020

Trademark Owner History


Party NameCureline, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Party NameCureline, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Party NameCureline, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Trademark Events


Event DateEvent Description
Friday, October 30, 2020NEW APPLICATION ENTERED
Thursday, December 17, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 26, 2021ASSIGNED TO EXAMINER
Thursday, April 1, 2021NON-FINAL ACTION WRITTEN
Thursday, April 1, 2021NON-FINAL ACTION E-MAILED
Thursday, April 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 4, 2021FINAL REFUSAL E-MAILED
Tuesday, May 4, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 21, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, April 21, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, May 4, 2021FINAL REFUSAL WRITTEN
Tuesday, September 14, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 14, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 14, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, September 14, 2021ASSIGNED TO LIE
Wednesday, September 15, 2021EXAMINER'S AMENDMENT ENTERED
Saturday, October 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, September 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED